InvestorsHub Logo
Followers 20
Posts 1031
Boards Moderated 0
Alias Born 10/17/2006

Re: scottsmith post# 74257

Friday, 08/26/2016 10:31:18 AM

Friday, August 26, 2016 10:31:18 AM

Post# of 458283
re: "We do know it's very safe. But not if it 'works.'"

Of course it works. We have proof from clinical trials that it works better than anything else out there. We just don't know how much better. It's a viable replacement for donepezil right now. The FDA requires p3 trials. I expect that the less sick the person is to begin with, the better it works. I also expect improvement to level off at some point. We are seeing a much better response well beyond donepezil, how long that can be sustained will be in future data.

Success is relative to the current standard of care drug which, as I may have mentioned, is crap.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News